DIN 02130955 — TYPHIM VI 25 MCG
TYPHIM VI is a solution of Salmonella typhi Ty2 Vi capsular polysaccharide marketed by SANOFI VACCINES CANADA LTD.. The full Salmonella typhi Ty2 Vi capsular polysaccharide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02130955
- Brand name
- TYPHIM VI
- Active ingredient
- Salmonella typhi Ty2 Vi capsular polysaccharide
- Strength
- 25 MCG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- SANOFI VACCINES CANADA LTD.
- Health Canada status
- MARKETED
- Drug class
- Inactivated polysaccharide vaccine (active immunizing agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.